logo
Plus   Neg
Share
Email

Bernie Sanders Calls For Legalization Of Marijuana

Senator Bernie Sanders has called for the legalization of marijuana at the federal level in the U.S.

On Sunday, the 2020 Democratic presidential candidate said on Twitter, "We must legalize marijuana nationally, expunge past marijuana convictions and ensure revenue from marijuana is reinvested in the communities most impacted by the failed War on Drugs."

Sanders also tweeted about how an audience member's father continued to languish in prison on marijuana charges as he cannot afford the cash required for bail, while in several states, marijuana is delivered to a user's home.

Sanders has released a criminal justice reform plan that says he will make the structural investments to rebuild the communities that mass incarceration continues to decimate, if he becomes president of the U.S.

"In fact, black Americans are incarcerated at five times the rate of white Americans, and even though people use drugs like marijuana at roughly the same rates across all races, black Americans are nearly four times more likely to be arrested for marijuana possession than white Americans. These disparities pervade every aspect of the criminal justice system," Sanders said on his website.

He noted that mass incarceration has not made the U.S. any safer or reduced drug use and addiction. Instead, it has cost lives and diverted resources that could be used to prevent crime through social investment.

The War on Drugs has disproportionately affected black and brown people, Sanders said.

The presidential candidate also urged the use of "therapeutic, not punitive solutions" to address drug addiction and called for change in federal laws to treat addiction as a mental health issue.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered. Gilead Sciences Inc. said it is donating its existing supply of 1.5 million individual doses of remdesivir, its investigational medicine for coronavirus or Covid-19. The drug, which is yet to get regulatory approval, is available for compassionate use, expanded access and clinical trials to treat patients with the most severe symptoms of COVID-19.
Follow RTT
>